Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genece Health
Del Mar, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Genece Health operates a CLIA-certified, CAP-accredited lab providing liquid biopsy-based cancer detection using low-pass whole genome sequencing and deep learning. Their platform analyzes genetic features to detect circulating tumor DNA in blood samples, with rapid reporting to clinicians and patients. Technology is already used in clinical practice via exclusive license from GC Genome[1][2][3].
- Therapeutic areas
- Oncology
- Modalities
- Liquid biopsyWhole genome sequencingMachine learning-based diagnostics
- Industry
- Molecular Diagnostics
02
Partnerships
GC Genome (GC Corporation, South Korea’s largest life sciences company)[1][2][3]
Beyond the preview
Go deeper on Genece Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genece Health.